Patanjali’s Partner Stops All Ayurveda Product Ads After Complaint Over Misleading Claims
Indian multinational conglomerate holding company, Patanjali Ayurved has withdrawn its advertisements after a complaint by a doctor in Kerala.
The doctor reportedly complained that a pharmacy promoted Patanjali’s products and stated that they cured diabetes, heart, and liver diseases.
Patanjali Withdraws Advertisements Of Medicines That Claim To Heal Diseases
The Kozhikode Divya Pharmacy is attached to Patanjali Ayurved and has stated that the advertisements of some specific products have been pulled down. According to the Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954, the ministry judged the commercials to be “objectionable and deceptive.”
In a letter to the Licensing Officer, Ayurvedic and Unani Services in Uttarakhand, an authorised representative of Divya Pharmacy stated, “The undersigned has immediately stopped publication of the impugned advertisements.” The Divya Pharmacy is a unit of Divya Yog Mandir Trust.
Dr. KV Babu, an ophthalmologist based in Kannur, registered a complaint against three advertisements published by Patanjali Ayurved. He alslo filed a Right to Information (RTI) request on March 1 seeking information on the progress of his complaint, to which he received a response on April 19 advising him to take action against the advertisements.
As per his complaint, “Drugs claiming to cure certain diseases cannot be advertised. These advertisements appeared in February. So I sent a complaint on February 24 to VG Somani, Drugs Controller General of India, opposing one of the advertisements that claimed the product would cure heart problems and blood pressure by reducing cholesterol in a week.”
This complaint was then forwarded to the AYUSH Ministry.
Not The First Time?
Amid the peak of the coronavirus pandemic last year, Baba Ramdev’s Patanjali Ayurveda launched the ‘world’s first Ayurveda’ based medicine for positive patients, which claimed to treat any Covid-19 patients within 5-14 days.
The Union Health Minister Harsh Vardhan was present on the launch of this drug.
The Indian Medical Association (IMA) on Monday expressed its fury on the ‘blatant lie of WHO certification’ claim made by Patanjali in regards to its Coronil tablet, while simultaneously demanding an explanation from the Union Health Minister Harsh Vardhan, under whose jurisdiction the time drug was launched.
The IMA also demanded the HM to address the nation’s queries on whether it was fair and appropriate to release such false claims to the whole country, especially during a pandemic.